PharVision Advisers’s Stitch Fix SFIX Stock Holding History

PharVision Advisers’s Portfolio SFIX Stock Details SFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-66,326	Closed	-$348K	–	555
2025 Q4	$348K	Buy	+66,326	New	+$303K	0.18%	197

Other funds holding SFIX

DGI

Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

WCAU

Working Capital Advisors (UK) London, United Kingdom $57.9M AUM 1.94% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PharVision Advisers's SFIX Position: Q1 2026 in Review

PharVision Advisers sold out of Stitch Fix (SFIX) in Q1 2026, closing a stake of 66,326 shares — an estimated $348K sold.

PharVision Advisers first reported a position in SFIX in Q4 2025 and held it in 1 quarter. The position peaked at $348K in Q4 2025. 192 funds tracked by Wall St. Rank hold SFIX as of Q1 2026.

PharVision Advisers reported no remaining Stitch Fix position as of Q1 2026 after selling out during the quarter.
PharVision Advisers sold 66,326 Stitch Fix shares in Q1 2026, an estimated $348K.
PharVision Advisers first reported a position in Stitch Fix in Q4 2025 and held it in 1 quarter.
PharVision Advisers's Stitch Fix position peaked at $348K in Q4 2025.
192 funds tracked by Wall St. Rank held Stitch Fix as of Q1 2026.

Based on PharVision Advisers's 13F filing for Q1 2026, filed 22 Apr 2026.